4.5 Article

The Impact of Mammography Screening Guideline Changes in a Universally Insured Population

Journal

JOURNAL OF WOMENS HEALTH
Volume 30, Issue 12, Pages 1720-1728

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/jwh.2020.8546

Keywords

mammography; breast cancer; screening; USPSTF recommendations; TRICARE; interrupted time series analysis

Funding

  1. U.S. Department of Defense, Defense Health Agency [HU0001-11-1-0023]

Ask authors/readers for more resources

The study found that the USPSTF guideline updates in 2009 had a small but lasting impact on breast cancer screening rates among universally insured women, with no differences observed across age groups, race, or beneficiary type.
Background: The U.S. Preventive Services Task Force (USPSTF) modified breast cancer screening guidelines in November 2009. The impact has been studied among privately and Medicare insured populations, but not among universally insured women. Materials and Methods: This study compared the proportion of TRICARE beneficiaries aged 40-64 receiving mammograms from fiscal years 2006 to 2015 using an interrupted time series analysis to determine the impact of the 2009 USPSTF guideline changes. Stratified analyses evaluated differences by age (ages 40-49, 50-64), race, care setting, beneficiary type, and military status. Results: The proportion of women receiving mammograms increased from October 2005 through September 2009. A small, but significant decrease of 65-66 fewer women screened per 10,000 occurred in the first quarter of 2010 (October 1 to December 31) following the screening guideline update publication. The proportion screened then remained unchanged through 2015. Comparative analysis revealed no differences in impact between age groups, blacks and whites, or military dependents and active-duty/retirees. Conclusions: This study determined that the USPSTF guideline updates had a small, but immediate and lasting impact that was not different across age groups, beneficiary type, or race. No racial disparities in the proportion screened or in the impact of the guideline change were noted in our universally insured population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available